Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:1138-1144
Published online before print February 11, 2008, doi: 10.1161/CIRCULATIONAHA.107.731794
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/9/1138    most recent
CIRCULATIONAHA.107.731794v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasan, R. S.
Right arrow Articles by Aviv, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasan, R. S.
Right arrow Articles by Aviv, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Clinical Trials
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Epidemiology
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2008;117:1138-1144.)
© 2008 American Heart Association, Inc.


Epidemiology

Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System

The Framingham Heart Study

Ramachandran S. Vasan, MD; Serkalem Demissie, PhD; Masayuki Kimura, MD, PhD; L. Adrienne Cupples, PhD; Nader Rifai, PhD; Charles White, MPH; Thomas J. Wang, MD; Jeffrey P. Gardner, PhD; Xiaogian Cao, BS; Emelia J. Benjamin, MD, ScM; Daniel Levy, MD; Abraham Aviv, MD

From the Framingham Heart Study of the National Heart, Lung, and Blood Institute, Framingham, Mass (R.S.V., S.D., L.A.C., E.J.B.); Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass (R.S.V., E.J.B.); Department of Biostatistics (S.D., L.A.C., C.W.) and Department of Epidemiology (L.A.C., E.J.B.), Boston University School of Public Health, Boston, Mass; Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (N.R.); Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (T.J.W.); National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (D.L.); and Center of Human Development and Aging, University of Medicine and Dentistry of New Jersey, Newark (M.K., J.P.G., X.C., A.A.).

Correspondence to Ramachandran S. Vasan, MD, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702–5827. E-mail vasan{at}bu.edu

Received August 2, 2007; accepted November 30, 2007.

Background— Leukocyte telomere length (LTL) chronicles the cumulative burden of oxidative stress and inflammation over a life course. Activation of the renin-angiotensin-aldosterone system is associated with increased oxidative stress and inflammation. Therefore, LTL may be related to circulating biomarkers of the renin-angiotensin-aldosterone system.

Methods and Results— We evaluated the cross-sectional relations of LTL (dependent variable) to circulating renin and aldosterone concentrations and the renin-to-aldosterone ratio (all logarithmically transformed; independent variables) in 1203 Framingham Study participants (mean age, 59 years; 51% women). We used multivariable linear regression and adjusted for age, blood pressure, hypertension treatment, smoking, diabetes mellitus, body mass index, hormone replacement therapy, serum creatinine, and the urine sodium-to-creatinine ratio. Overall, multivariable-adjusted LTL was inversely related to renin (β coefficient per unit increase, –0.038; P=0.036), directly related to aldosterone (β=0.099; P=0.002), and inversely related to the renin-to-aldosterone ratio (β=–0.049; P=0.003). Relations of LTL to biomarkers were stronger in those with hypertension, although a formal test of interaction was not statistically significant (P=0.20). Individuals with hypertension displayed significant associations of LTL with renin (β=–0.060; P=0.005), aldosterone (β=0.134; P=0.002), and renin-to-aldosterone ratio (β=–0.072; P<0.001). Participants with hypertension who were in the top tertile of the renin-to-aldosterone ratio had LTL that was 182 base pairs shorter relative to those in the lowest tertile.

Conclusions— In our community-based sample, LTL was shorter in individuals with a higher renin-to-aldosterone ratio, especially in participants with hypertension. Additional investigations are warranted to confirm our observations.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 1121-1123. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J Gerontol A Biol Sci Med SciHome page
R. C. Kaplan, A. L. Fitzpatrick, M. N. Pollak, J. P. Gardner, N. S. Jenny, A. P. McGinn, L. H. Kuller, H. D. Strickler, M. Kimura, B. M. Psaty, et al.
Insulin-Like Growth Factors and Leukocyte Telomere Length: The Cardiovascular Health Study
J Gerontol A Biol Sci Med Sci, April 6, 2009; (2009) glp036v1.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Yang, X. Huang, H. Jiang, Y. Zhang, H. Liu, C. Qin, G. M. Eisner, P. Jose, L. Rudolph, and Z. Ju
Short Telomeres and Prognosis of Hypertension in a Chinese Population
Hypertension, April 1, 2009; 53(4): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Aviv, W. Chen, J. P. Gardner, M. Kimura, M. Brimacombe, X. Cao, S. R. Srinivasan, and G. S. Berenson
Leukocyte Telomere Dynamics: Longitudinal Findings Among Young Adults in the Bogalusa Heart Study
Am. J. Epidemiol., February 1, 2009; 169(3): 323 - 329.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing
Cardiovasc Res, February 1, 2009; 81(2): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Huzen, D. J. van Veldhuisen, and P. van der Harst
Letter by Huzen et al Regarding Article, "Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System: The Framingham Heart Study"
Circulation, November 4, 2008; 118(19): e688 - e688.
[Full Text] [PDF]


Home page
CirculationHome page
R. S. Vasan, S. Demissie, L. A. Cupples, E. J. Benjamin, C. White, M. Kimura, J. P. Gardner, X. Cao, A. Aviv, N. Rifai, et al.
Response to Letter Regarding Article, "Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System: The Framingham Heart Study"
Circulation, November 4, 2008; 118(19): e689 - e689.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
L. S.M. Wong, R. A. de Boer, N. J. Samani, D. J. van Veldhuisen, and P. van der Harst
Telomere biology in heart failure
Eur J Heart Fail, November 1, 2008; 10(11): 1049 - 1056.
[Abstract] [Full Text] [PDF]